JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB146123

CX 546, AMPA receptor potentiator

Be the first to review this product! Submit a review

|

(0 Publication)

MW 247.29 Da, Purity >99%. AMPA receptor potentiator. Selectively binds to the agonist bound non-desensitized receptor. Destabilizes desensitized receptor conformation with greater potency than CX516. Enhances cognitive function in vivo. .

View Alternative Names

15-PGDH, 15-hydroxyprostaglandin dehydrogenase [NAD+], Hpgd, Hydroxyprostaglandin dehydrogenase 15 (NAD), NAD+ dependent 15 hydroxyprostaglandin dehydrogenase, OTTHUMP00000218960, OTTHUMP00000219016, OTTHUMP00000219018, PGDH1, PGDH_HUMAN, PHOAR1, Prostaglandin dehydrogenase 1, SDR36C1, Short chain dehydrogenase/reductase family 36C member 1

1 Images
Chemical Structure - CX 546, AMPA receptor potentiator (AB146123)
  • Chemical Structure

Lab

Chemical Structure - CX 546, AMPA receptor potentiator (AB146123)

2D chemical structure image of ab146123, CX 546, AMPA receptor potentiator

Key facts

CAS number

215923-54-9

Purity

>99%

Form

Solid

form

Molecular weight

247.29 Da

Molecular formula

C<sub>1</sub><sub>4</sub>H<sub>1</sub><sub>7</sub>NO<sub>3</sub>

PubChem

2890

Nature

Synthetic

Solubility

Soluble in ethanol to 100 mM

Soluble in DMSO to 100 mM

Biochemical name

(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)(piperidin-1-yl)methanone

Biological description

AMPA receptor potentiator. Selectively binds to the agonist bound non-desensitized receptor. Destabilizes desensitized receptor conformation with greater potency than CX516. Enhances cognitive function in vivo.

Canonical smiles

C1CCN(CC1)C(=O)C2=CC3=C(C=C2)OCCO3

InChi

InChI=1S/C14H17NO3/c16-14(15-6-2-1-3-7-15)11-4-5-12-13(10-11)18-9-8-17-12/h4-5,10H,1-3,6-9H2

InChiKey

LJUNPHMOGNFFOS-UHFFFAOYSA-N

IUPAC Name

2,3-dihydro-1,4-benzodioxin-6-yl(piperidin-1-yl)methanone

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
It is important to note that this product is reported to be light sensitive|Store in the dark|Store under desiccating conditions

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

15-PGDH also known as 15-hydroxyprostaglandin dehydrogenase PGDH or 15-PGDH protein is an enzyme with a molecular mass of approximately 29 kDa. This enzyme catalyzes the oxidation of the 15-hydroxyl group in prostaglandins specifically converting Prostaglandin E2 (PGE2) into its inactive form. Expression occurs in various tissues including the lung placenta and colonic epithelium. Its activity levels can vary depending on the tissue context and physiological conditions marking its importance in local regulation.
Biological function summary

15-PGDH regulates prostaglandin levels which are lipid compounds playing roles in inflammation and homeostasis. This enzyme does not associate with protein complexes but serves a standalone function in metabolic pathways. It maintains a balance between prostaglandin synthesis and degradation ensuring that inflammatory responses do not exceed what is necessary. The enzyme's activity directly reduces available prostaglandins which in turn dampens related signaling pathways.

Pathways

Prostaglandins and this enzyme are part of arachidonic acid metabolism and the Cyclooxygenase (COX) pathway. These pathways play key roles in inflammation and tissue homeostasis. 15-PGDH interacts with other enzymes like COX-2 as it acts downstream to mitigate PGE2 levels generated by COX enzymes. This diminishes the signaling of other elements such as the AMPA receptors involved in neuronal plasticity and pain perception showcasing the enzyme's regulatory scope within biological systems.

15-PGDH plays a role in colon cancer and pulmonary inflammation. Low expression or activity of this enzyme is associated with increased PGE2 levels contributing to cancer progression and chronic inflammation. This dysregulation may involve proteins like COX-2 where the imbalance between synthesis and degradation leads to elevated prostaglandin signaling. Understanding 15-PGDH functions offers insights into therapeutic potentials making inhibitors and potentiators of interest for treatment of these conditions.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com